• A
  • A
Font Size
EYLEA co-pay card

Do I qualify for the EYLEA Co-Pay Card?

  • Is your EYLEA co-pay more than $5 for each treatment?
  • Does your insurance cover EYLEA for an approved use?
  • Are you a resident of the United States or its territories or possessions?

If you answered yes to the above questions, you may qualify for the EYLEA Co-Pay Card Program. To apply, call an EYLEA4U Support Specialist at 1-855-EYLEA4U (1-855-395-3248) and press Option 4 Monday through Friday 9 AM to 8 PM Eastern Time.

What does the EYLEA Co-Pay Card Program cover?*

*This program is not valid for prescriptions covered by or submitted for reimbursement under Medicaid, Medicare, VA DOD, TRICARE, or similar federal or state programs. This program is not an insurance benefit. The program does not cover or provide support for supplies, procedures, or any physician-related service associated with EYLEA. General, non–product-specific co-pay, co-insurance, or insurance deductibles are not covered. This program is not valid where prohibited by law, taxed, or restricted. EYLEA4U reserves the right to rescind, revoke, terminate, or amend this offer, eligibility, and terms of use at any time without notice. Additional program conditions apply.

The EYLEA Co-Pay Card Program covers up to $10,000 in assistance per year toward product-specific co-pay, co-insurance, and insurance deductibles for EYLEA treatments. You pay the first $5 of each treatment and any additional co-pay costs that exceed the program limits.

Can you show me an example of how the EYLEA Co-Pay Card Program works?

Yes. Let's say you have commercial health coverage, and pay $490 in out-of-pocket co-pay/co-insurance for each EYLEA treatment. If you enroll in the EYLEA Co-Pay Card Program, you would pay $5 for a co-pay, and the program would cover the remaining $485 if you have not exceeded the $10,000 per-year limit. Any cost above the limit would be your responsibility.

EYLEA Co-Pay Support

To learn more about how EYLEA4U can help you, enroll today. The process is simple. You or your eye doctor's office can call 1-855-EYLEA4U (1-855-395-3248) Monday through Friday 9 AM to 8 PM Eastern Time to get started.


We've got you covered

When your eye doctor prescribes EYLEA, whether you have private or government insurance (Medicare/Medicaid) or have no insurance coverage, you can be confident that EYLEA4U is here to help. And we can conduct a Benefits Investigation with your insurer to determine your coverage for EYLEA.


Support Specialists

Your live link to EYLEA4U

EYLEA4U Support Specialists are your link to the EYLEA4U support programs. They will listen to your story, answer your questions, and help determine what support program may work for you.

Right from the start, EYLEA4U Support Specialists are ready to help by:

  • Providing information about your health plan
  • Finding the support program that's best for you
  • Working with your doctor's office and health plan to help determine your coverage

Getting support

When we say "we're here for you," we stand behind it—online and by phone at 1-855-EYLEA4U (1-855-395-3248) 9 AM to 8 PM Eastern Time (press 2 for Medical Information questions, 3 to report an adverse event, 4 for patient assistance programs, and 6 if you need help getting to and from your eye appointments).

Important Safety Information
  • EYLEA® (aflibercept) Injection is a prescription medication administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
Top
Important Safety Information
  • EYLEA® (aflibercept) Injection is a prescription medication administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injection into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye). Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential risk of serious and sometimes fatal side effects related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • Serious side effects related to the injection procedure with EYLEA are rare but can occur including infection inside the eye and retinal detachment.
  • The most common side effects reported in patients receiving EYLEA are increased redness in the eye, eye pain, cataract, moving spots in the field of vision, increased pressure in the eye, and vitreous (gel-like substance) detachment.
  • It is important that you contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • EYLEA is for prescription use only. For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Indications

EYLEA® (aflibercept) Injection is a prescription medicine approved for the treatment of patients with:

  • Wet Age-related Macular Degeneration (AMD): The recommended dose for EYLEA is 2 mg administered by injection in the eye every 2 months (8 weeks) following 3 initial monthly (every 4 weeks) injections. EYLEA may be dosed once per month, but in most patients, additional benefit was not seen with this dosing plan. Some patients may need monthly (every 4 weeks) dosing after the first 3 months (12 weeks).
  • Macular Edema following Retinal Vein Occlusion (RVO): The recommended dose for EYLEA is 2 mg administered by injection in the eye monthly (every 4 weeks).
  • Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR) in patients with DME: The recommended dose for EYLEA is 2 mg administered by injection in the eye every 2 months (8 weeks) following 5 initial monthly (every 4 weeks) injections. EYLEA may be dosed once per month, but in most patients, additional benefit was not seen with this dosing plan. Some patients may need monthly (every 4 weeks) dosing after the first 5 months (20 weeks).
Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.